Cellular and T cell engager Immunotherapy
CMV Reactivation During Treatment with Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma
Eric M. Jurgens, MD
Fellow, Hematology and Medical Oncology
Department of Medicine, Memorial Sloan Kettering Cancer Center, United States